Nef-M1 treated tumor cells analyzed via western blot displayed increased expression of the epithelial signature E-cadherin and decreased expression of the mesenchymal signature vimentin, fibronectin, and p-GSK-3β (Figure 5A & 5B). This evidence concerns the gene S100B and neoplasm.